Feanix Biotechnologies Raises $5.3M to Scale AI-Driven Genomics Platform for Livestock Breeding
Feanix Biotechnologies, an agricultural genomics startup focused on applying artificial intelligence and DNA analytics to livestock breeding, has raised significant early-stage capital as it works to modernize decision-making across animal agriculture. Founded in 2021, the company develops genomic tools that help livestock producers improve herd health, productivity, and sustainability through data-driven breeding strategies. Its platform combines DNA testing with machine learning models to predict economically and biologically important traits in animals, aiming to replace traditional trial-and-error approaches with precision insights.
The company first secured institutional backing through a pre-seed investment from Y Combinator in 2023. Participation in the accelerator program provided Feanix with initial capital as well as access to mentorship, technical resources, and a broad network of founders and investors. The early funding supported product validation, pilot programs with livestock producers, and the development of its core genomic analytics infrastructure.
Following the initial raise, Feanix went on to attract additional venture capital as it expanded its technology and commercial footprint. The company has disclosed backing from Initialized Capital, General Catalyst, Collab Capital, and Overwater Ventures, alongside a group of angel investors with experience in biotechnology, agriculture, and data science. These investors collectively contributed to a larger seed round that brought Feanix’s total disclosed funding to approximately $5.3 million.
The capital infusion is being used to scale Feanix’s proprietary AI-powered genomics platform, often referred to internally as Feanix Autopilot. The system integrates whole-genome sequencing data with farm-level performance and health metrics to generate predictive insights for breeders and producers. By identifying animals with optimal genetic traits earlier and more accurately, the company aims to help farms increase efficiency, reduce costs, and improve long-term sustainability outcomes.
Investor interest in Feanix reflects broader momentum at the intersection of agriculture, biotechnology, and artificial intelligence. Livestock producers are increasingly seeking tools that can help them respond to rising input costs, climate-related challenges, and growing demand for sustainable food production. Feanix positions its technology as a way to optimize breeding programs while minimizing environmental impact, aligning economic incentives with sustainability goals.
The company is led by co-founder and chief executive officer Mitchell Angove, alongside a technical leadership team with backgrounds in genetics, computational biology, and data science. Under their direction, Feanix has expanded its customer base and reported steady revenue growth as more producers adopt genomic testing and predictive analytics as part of routine operations. The team has emphasized that funding will also support hiring across engineering, bioinformatics, and customer success roles as demand for its services increases.
Beyond platform development, Feanix plans to broaden the scope of species and traits covered by its analytics, extending applications across multiple livestock categories. The company sees long-term potential in becoming a foundational data layer for animal agriculture, enabling more consistent outcomes across breeding, health management, and production planning.
With backing from established venture firms and early validation in the market, Feanix Biotechnologies enters its next phase with a strengthened balance sheet and growing industry visibility. As precision agriculture continues to gain traction, the company’s funding milestone underscores rising investor confidence in genomic intelligence as a critical tool for the future of livestock production.
